Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.32 M1.2 M1.03 M1.42 M1.21 M 4.85 M Research & development ————— — Operating income -1.31 M-1.2 M-826 K-1.54 M-686 K -4.25 M Non-Operating Income, Total ————— — Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income -1.14 M-1.04 M-694 K-1.42 M-566 K -3.73 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest ————— — After tax other income/expense ————120 K — Net income before discontinued operations -1.14 M-1.04 M-694 K-1.42 M-566 K -3.73 M Discontinued operations ————— — Net income -1.14 M-1.04 M-694 K-1.42 M-566 K -3.73 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -1.14 M-1.04 M-694 K-1.42 M-566 K -3.73 M Basic earnings per share (Basic EPS) -0.05-0.05-0.03-0.07-0.03 -0.18 Diluted earnings per share (Diluted EPS) -0.05-0.05-0.03-0.07-0.03 -0.18 Average basic shares outstanding 21.04 M21.04 M21.04 M21.04 M21.04 M — Diluted shares outstanding 21.04 M21.04 M21.04 M21.04 M21.04 M — EBITDA -1.12 M-1.02 M-673 K-1.4 M-551 K -3.65 M EBIT -1.14 M-1.04 M-694 K-1.42 M-566 K -3.73 M Cost of revenue 1.66 M1.22 M1.69 M1.65 M534 K 5.09 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 20 K21 K21 K20 K15 K 77 K